{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:33:03Z","timestamp":1789770783466,"version":"4.0.1"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111\u20132314-B-182A-104"],"award-info":[{"award-number":["111\u20132314-B-182A-104"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 110\u20132314-B-182A-127-MY3"],"award-info":[{"award-number":["MOST 110\u20132314-B-182A-127-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG1M0021"],"award-info":[{"award-number":["CMRPG1M0021"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["NMRPG3M0081"],"award-info":[{"award-number":["NMRPG3M0081"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bcp.2023.115622","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T15:37:51Z","timestamp":1684856271000},"page":"115622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Potential therapeutic targets beyond cytokines and Janus kinases for autoimmune arthritis"],"prefix":"10.1016","volume":"213","author":[{"given":"Chao-Yi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6266-705X","authenticated-orcid":false,"given":"Jenn-Haung","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.bcp.2023.115622_b0005","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.bcp.2023.115622_b0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.berh.2018.10.004","article-title":"Update on the epidemiology, risk factors and disease outcomes of Juvenile idiopathic arthritis","volume":"32","author":"Palman","year":"2018","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115622_b0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid Arthritis - Common Origins","volume":"388","author":"Longo","year":"2023","journal-title":"Divergent Mechanisms. N Engl J Med"},{"issue":"6","key":"10.1016\/j.bcp.2023.115622_b0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/annrheumdis-2019-216656","article-title":"Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis","volume":"79","author":"Kerschbaumer","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2023.115622_b0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bcp.2019.03.007","article-title":"Useful message in choosing optimal biological agents for patients with autoimmune arthritis","volume":"165","author":"Lai","year":"2019","journal-title":"Biochem. Pharmacol"},{"key":"10.1016\/j.bcp.2023.115622_b0030","doi-asserted-by":"crossref","unstructured":"Janke K, Biester K, Krause D, Richter B, Schurmann C, Hirsch K, et al. Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data. BMJ 2020;370:m2288.","DOI":"10.1136\/bmj.m2288"},{"issue":"8","key":"10.1016\/j.bcp.2023.115622_b0035","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3390\/cells8080927","article-title":"Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis","volume":"8","author":"Lai","year":"2019","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.bcp.2023.115622_b0040","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s10067-019-04699-8","article-title":"A comprehensive review of rituximab therapy in rheumatoid arthritis patients","volume":"38","author":"Tavakolpour","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115622_b0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","article-title":"Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach","volume":"18","author":"Tanaka","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"18","key":"10.1016\/j.bcp.2023.115622_b0050","first-page":"1768","article-title":"Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"Reply. N Engl J Med"},{"issue":"1","key":"10.1016\/j.bcp.2023.115622_b0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41584-020-00541-7","article-title":"Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis","volume":"17","author":"Buch","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115622_b0060","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/art.20982","volume":"52","author":"Smolen","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.bcp.2023.115622_b0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev-physiol-021119-034332","article-title":"The osteocyte: new insights","volume":"82","author":"Robling","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bcp.2023.115622_b0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fendo.2020.00165","article-title":"WNT signaling and bone: lessons from skeletal dysplasias and disorders","volume":"11","author":"Huybrechts","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"10.1016\/j.bcp.2023.115622_b0075","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00223-017-0373-1","article-title":"Bone loss in rheumatoid arthritis: basic mechanisms and clinical implications","volume":"102","author":"Shim","year":"2018","journal-title":"Calcif. Tissue Int."},{"issue":"9","key":"10.1016\/j.bcp.2023.115622_b0080","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1074\/jbc.M705092200","article-title":"Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost\/sclerostin","volume":"283","author":"Robling","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2023.115622_b0085","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.3390\/ijms23052871","article-title":"Inflammation and bone metabolism in rheumatoid arthritis: molecular mechanisms of joint destruction and pharmacological treatments","volume":"23","author":"Maeda","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2023.115622_b0090","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41574-020-0341-0","article-title":"Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment","volume":"16","author":"Chotiyarnwong","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bcp.2023.115622_b0095","article-title":"The mechanosensory role of osteocytes and implications for bone health and disease states","volume":"9","author":"Choi","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"19","key":"10.1016\/j.bcp.2023.115622_b0100","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.3390\/ijms221910659","article-title":"Vitamin D and rheumatic diseases: a review of clinical evidence","volume":"22","author":"Charoenngam","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115622_b0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.38291","article-title":"Review: The interleukin-23\/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond","volume":"66","author":"Smith","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bcp.2023.115622_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.788940","article-title":"The role of helper T cells in psoriasis","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2023.115622_b0115","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1136\/ard.2007.080341","article-title":"Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis","volume":"67","author":"Yamada","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.bcp.2023.115622_b0120","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192048","article-title":"Interleukin-17 in rheumatoid arthritis: trials and tribulations","volume":"217","author":"Taams","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2023.115622_b0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/bs.pmbts.2015.07.021","article-title":"Regulatory T cells in arthritis","volume":"136","author":"Komatsu","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.bcp.2023.115622_b0130","doi-asserted-by":"crossref","unstructured":"Tyagi AM, Yu M, Darby TM, Vaccaro C, Li JY, Owens JA, et al. The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression. Immunity 2018;49(6):1116-31 e7.","DOI":"10.1016\/j.immuni.2018.10.013"},{"issue":"12","key":"10.1016\/j.bcp.2023.115622_b0135","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.bcp.2023.115622_b0140","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.ajpath.2015.07.017","article-title":"Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis","volume":"185","author":"Kim","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115622_b0145","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ni.3579","article-title":"Regulation of autoantibody activity by the IL-23-T(H)17 axis determines the onset of autoimmune disease","volume":"18","author":"Pfeifle","year":"2017","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115622_b0150","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7651","article-title":"Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss","volume":"6","author":"Harre","year":"2015","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bcp.2023.115622_b0155","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.immuni.2018.04.009","article-title":"Autoimmune Th17 cells induced synovial stromal and innate lymphoid cell secretion of the cytokine GM-CSF to initiate and augment autoimmune arthritis","volume":"48","author":"Hirota","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bcp.2023.115622_b0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2023.115622_b0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13075-016-0998-x","article-title":"IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis","volume":"18","author":"Shaw","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2023.115622_b0170","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.20001","article-title":"Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion","volume":"50","author":"Lubberts","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2023.115622_b0175","doi-asserted-by":"crossref","first-page":"10928","DOI":"10.1038\/ncomms10928","article-title":"IL-17-producing gammadelta T cells enhance bone regeneration","volume":"7","author":"Ono","year":"2016","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bcp.2023.115622_b0180","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41584-018-0091-8","article-title":"Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis","volume":"14","author":"Gravallese","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"10.1016\/j.bcp.2023.115622_b0185","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/annrheumdis-2019-215356","article-title":"The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies","volume":"78","author":"McGonagle","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"7639","key":"10.1016\/j.bcp.2023.115622_b0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bcp.2023.115622_b0195","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150274","article-title":"Plasma cells promote osteoclastogenesis and periarticular bone loss in autoimmune arthritis","volume":"131","author":"Komatsu","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.bcp.2023.115622_b0200","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/jbmr.2800","article-title":"Activation of mTORC1 in B lymphocytes promotes osteoclast formation via regulation of beta-catenin and RANKL\/OPG","volume":"31","author":"Xu","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bcp.2023.115622_b0205","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/art.39489","article-title":"Production of RANKL by memory B cells: a link between B cells and bone erosion in rheumatoid arthritis","volume":"68","author":"Meednu","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115622_b0210","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.3390\/ijms21114015","article-title":"Anti-citrullinated protein antibodies in patients with rheumatoid arthritis: biological effects and mechanisms of immunopathogenesis","volume":"21","author":"Wu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2023.115622_b0215","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/annrheumdis-2015-208093","article-title":"Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss","volume":"75","author":"Krishnamurthy","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2023.115622_b0220","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/annrheumdis-2014-206015","article-title":"MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study","volume":"75","author":"Peterfy","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.bcp.2023.115622_b0225","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1136\/ard.2010.141549","article-title":"Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab","volume":"70","author":"Herenius","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2023.115622_b0230","doi-asserted-by":"crossref","unstructured":"Mahmoud DE, Kaabachi W, Sassi N, Tarhouni L, Rekik S, Jemmali S, et al. The synovial fluid fibroblast-like synoviocyte: A long-neglected piece in the puzzle of rheumatoid arthritis pathogenesis. Front Immunol 2022;13:942417.","DOI":"10.3389\/fimmu.2022.942417"},{"issue":"15","key":"10.1016\/j.bcp.2023.115622_b0235","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.3390\/ijms22157960","article-title":"Signals and mechanisms regulating monocyte and macrophage activation in the pathogenesis of juvenile idiopathic arthritis","volume":"22","author":"Wu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2023.115622_b0240","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41584-022-00790-8","article-title":"Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission","volume":"18","author":"Kurowska-Stolarska","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7771","key":"10.1016\/j.bcp.2023.115622_b0245","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41586-019-1471-1","article-title":"Locally renewing resident synovial macrophages provide a protective barrier for the joint","volume":"572","author":"Culemann","year":"2019","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bcp.2023.115622_b0250","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","article-title":"Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis","volume":"26","author":"Alivernini","year":"2020","journal-title":"Nat. Med."},{"issue":"491","key":"10.1016\/j.bcp.2023.115622_b0255","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau8587","article-title":"HBEGF(+) macrophages in rheumatoid arthritis induce fibroblast invasiveness","volume":"11","author":"Kuo","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.bcp.2023.115622_b0260","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1073\/pnas.050574297","article-title":"Expression and function of wingless and frizzled homologs in rheumatoid arthritis","volume":"97","author":"Sen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.bcp.2023.115622_b0265","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/annrheumdis-2014-207137","article-title":"RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation","volume":"75","author":"Danks","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.bcp.2023.115622_b0270","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115622_b0275","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bcp.2023.115622_b0280","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.2653","article-title":"Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis","volume":"18","author":"Maeda","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2023.115622_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.555245","article-title":"Non-canonical WNT5A signaling through RYK contributes to aggressive phenotype of the rheumatoid fibroblast-like synoviocytes","volume":"11","author":"Rodriguez-Trillo","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115622_b0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01692-7","article-title":"Phenotypic and functional characterization of synovial fluid-derived fibroblast-like synoviocytes in rheumatoid arthritis","volume":"11","author":"K\u00f8ster","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2023.115622_b0295","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","article-title":"Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions","volume":"18","author":"Komatsu","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10","key":"10.1016\/j.bcp.2023.115622_b0300","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1136\/ard.2011.150219","article-title":"A BAFF\/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells","volume":"70","author":"Bombardieri","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.bcp.2023.115622_b0305","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJMoa2004114","article-title":"RNA identification of PRIME cells predicting rheumatoid arthritis flares","volume":"383","author":"Orange","year":"2020","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.bcp.2023.115622_b0310","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fphar.2016.00184","article-title":"Hypoxia-inducible factor (HIF) as a target for novel therapies in rheumatoid arthritis","volume":"7","author":"Hua","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115622_b0315","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.molimm.2021.12.004","article-title":"STAT3\/HIF-1alpha\/fascin-1 axis promotes RA FLSs migration and invasion ability under hypoxia","volume":"142","author":"Yang","year":"2022","journal-title":"Mol. Immunol."},{"issue":"Pt A","key":"10.1016\/j.bcp.2023.115622_b0320","article-title":"Targeted inhibition of the GRK2\/HIF-1alpha pathway is an effective strategy to alleviate synovial hypoxia and inflammation","volume":"113","author":"Hong","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115622_b0325","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.immuni.2021.03.003","article-title":"The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts","volume":"54","author":"Friscic","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2023.115622_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1107670","article-title":"Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs","volume":"14","author":"Jing","year":"2023","journal-title":"Front. Immunol."},{"issue":"7760","key":"10.1016\/j.bcp.2023.115622_b0335","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2023.115622_b0340","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-02892-y","article-title":"Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis","volume":"9","author":"Mizoguchi","year":"2018","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.bcp.2023.115622_b0345","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1073\/pnas.1019437108","article-title":"Cadherin-11 regulates fibroblast inflammation","volume":"108","author":"Chang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.bcp.2023.115622_b0350","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat. Immunol."},{"issue":"7811","key":"10.1016\/j.bcp.2023.115622_b0355","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-020-2222-z","article-title":"Notch signalling drives synovial fibroblast identity and arthritis pathology","volume":"582","author":"Wei","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2023.115622_b0360","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41467-018-02935-4","article-title":"The p55TNFR-IKK2-Ripk3 axis orchestrates arthritis by regulating death and inflammatory pathways in synovial fibroblasts","volume":"9","author":"Armaka","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.bcp.2023.115622_b0365","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.immuni.2017.01.004","article-title":"Autocrine loop involving IL-6 family member LIF, LIF receptor, and STAT4 drives sustained fibroblast production of inflammatory mediators","volume":"46","author":"Nguyen","year":"2017","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.bcp.2023.115622_b0370","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1074\/jbc.M106339200","article-title":"Expression of the osteoblast differentiation factor RUNX2 (Cbfa1\/AML3\/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha","volume":"277","author":"Gilbert","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"330","key":"10.1016\/j.bcp.2023.115622_b0375","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4351","article-title":"Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction","volume":"8","author":"Wehmeyer","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.bcp.2023.115622_b0380","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/annrheumdis-2012-202184","article-title":"Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis","volume":"72","author":"de Rooy","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.bcp.2023.115622_b0385","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/03009742.2015.1126347","article-title":"Inflammation in arthritis induces expression of BMP3, an inhibitor of bone formation","volume":"45","author":"Matzelle","year":"2016","journal-title":"Scand. J. Rheumatol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115622_b0390","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.39086","article-title":"Semaphorin 4D contributes to rheumatoid arthritis by inducing inflammatory cytokine production: pathogenic and therapeutic implications","volume":"67","author":"Yoshida","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bcp.2023.115622_b0395","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ebiom.2019.02.009","article-title":"Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis","volume":"41","author":"He","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bcp.2023.115622_b0400","doi-asserted-by":"crossref","first-page":"155652","DOI":"10.1016\/j.cyto.2021.155652","article-title":"CX3CL1\/fractalkine regulates the differentiation of human peripheral blood monocytes and monocyte-derived dendritic cells into osteoclasts","volume":"146","author":"Muraoka","year":"2021","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.bcp.2023.115622_b0405","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/s41590-019-0526-7","article-title":"Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1","volume":"20","author":"Hasegawa","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2023.115622_b0410","doi-asserted-by":"crossref","first-page":"115616","DOI":"10.1016\/j.bone.2020.115616","article-title":"Human dendritic cell-derived osteoclasts with high bone resorption capacity and T cell stimulation ability","volume":"142","author":"Narisawa","year":"2021","journal-title":"Bone"},{"issue":"14","key":"10.1016\/j.bcp.2023.115622_b0415","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.3390\/ijms21145169","article-title":"Osteocyte-related cytokines regulate osteoclast formation and bone resorption","volume":"21","author":"Kitaura","year":"2020","journal-title":"Int. J Mol. Sci."},{"key":"10.1016\/j.bcp.2023.115622_b0420","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1038\/ncomms7637","article-title":"Immune complexes regulate bone metabolism through FcRgamma signalling","volume":"6","author":"Negishi-Koga","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2023.115622_b0425","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","article-title":"Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin","volume":"122","author":"Harre","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2023.115622_b0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bonr.2018.05.006","article-title":"Effect of a cathepsin K inhibitor on arthritis and bone mineral density in ovariectomized rats with collagen-induced arthritis","volume":"9","author":"Yamashita","year":"2018","journal-title":"Bone Rep."},{"issue":"4","key":"10.1016\/j.bcp.2023.115622_b0435","first-page":"500","article-title":"Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis","volume":"17","author":"Yoshihara","year":"2007","journal-title":"Clin. Calcium"},{"issue":"7","key":"10.1016\/j.bcp.2023.115622_b0440","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/annrheumdis-2018-214827","volume":"78","author":"Takeuchi","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"22","key":"10.1016\/j.bcp.2023.115622_b0445","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.3390\/ijms20225552","article-title":"Wnt signaling and biological therapy in rheumatoid arthritis and spondyloarthritis","volume":"20","author":"Cici","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2023.115622_b0450","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/ar4305","article-title":"Effect of sclerostin-neutralising antibody on periarticular and systemic bone in a murine model of rheumatoid arthritis: a microCT study","volume":"15","author":"Marenzana","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"10","key":"10.1016\/j.bcp.2023.115622_b0455","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1136\/annrheumdis-2013-203345","article-title":"Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis","volume":"72","author":"Chen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2023.115622_b0460","doi-asserted-by":"crossref","unstructured":"Kobayakawa T, Miyazaki A, Kanayama Y, Hirano Y, Takahashi J, Suzuki T, et al. Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration. Mod Rheumatol 2023;33(1):96-103.","DOI":"10.1093\/mr\/roac014"},{"issue":"1","key":"10.1016\/j.bcp.2023.115622_b0465","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13075-017-1353-6","article-title":"Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis","volume":"19","author":"Lee","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.bcp.2023.115622_b0470","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1002\/art.30573","article-title":"CXCL10 and its receptor CXCR3 regulate synovial fibroblast invasion in rheumatoid arthritis","volume":"63","author":"Laragione","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.bcp.2023.115622_b0475","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/art.41555","article-title":"Efficacy and safety of E6011, an anti-fractalkine monoclonal antibody, in patients with active rheumatoid arthritis with inadequate response to methotrexate: results of a randomized, double-blind. Placebo-controlled phase II study","volume":"73","author":"Tanaka","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115622_b0480","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/art.34330","article-title":"A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis","volume":"64","author":"Yellin","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.bcp.2023.115622_b0485","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s12276-020-0484-z","article-title":"The M-CSF receptor in osteoclasts and beyond","volume":"52","author":"Mun","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.bcp.2023.115622_b0490","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3899\/jrheum.141580","article-title":"Results from a phase IIA parallel group study of JNJ-40346527, an oral CSF-1R Inhibitor, in patients with active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy","volume":"42","author":"Genovese","year":"2015","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.bcp.2023.115622_b0495","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1136\/annrheumdis-2014-205234","article-title":"Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis","volume":"74","author":"Greven","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.bcp.2023.115622_b0500","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1016\/S2665-9913(20)30229-0","article-title":"Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study","volume":"2","author":"Buckley","year":"2020","journal-title":"The Lancet Rheum."},{"issue":"11","key":"10.1016\/j.bcp.2023.115622_b0505","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1016\/S2665-9913(20)30224-1","article-title":"MRI of the joint and evaluation of the granulocyte\u2013macrophage colony-stimulating factor\u2013CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study","volume":"2","author":"Genovese","year":"2020","journal-title":"The Lancet Rheum."},{"issue":"5814","key":"10.1016\/j.bcp.2023.115622_b0510","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1137306","article-title":"Cadherin-11 in synovial lining formation and pathology in arthritis","volume":"315","author":"Lee","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.bcp.2023.115622_b0515","doi-asserted-by":"crossref","unstructured":"Finch R, Sostelly A, Sue-Ling K, Blaeuer A, Duchateau-Nguyen G, Ukarma L, et al. OP0224 results of a phase 2 study of rg6125, an anti-cadherin-11 monoclonal antibody, in rheumatoid arthritis patients with an inadequate response to anti-tnfalpha therapy. Annals of the Rheumatic Diseases 2019;78(Suppl 2):189-.","DOI":"10.1136\/annrheumdis-2019-eular.3028"},{"key":"10.1016\/j.bcp.2023.115622_b0520","doi-asserted-by":"crossref","unstructured":"Dorst DN, Rijpkema M, Buitinga M, Walgreen B, Helsen MMA, Brennan E, et al. Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy. Rheumatology (Oxford) 2022;61(7):2999-3009.","DOI":"10.1093\/rheumatology\/keab664"},{"key":"10.1016\/j.bcp.2023.115622_b0525","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.omtn.2020.01.014","article-title":"Downregulation of hypoxia-inducible factor-1alpha by RNA interference alleviates the development of collagen-induced arthritis in rats","volume":"19","author":"Hu","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bcp.2023.115622_b0530","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/bs.pmbts.2017.03.003","article-title":"Matrix metalloproteinases and synovial joint pathology","volume":"148","author":"Malemud","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115622_b0535","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1023\/A:1018373520193","article-title":"Matrix metalloproteinase inhibitors","volume":"1","author":"Brown","year":"1998","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bcp.2023.115622_b0540","unstructured":"Kim S CB, Tong L, Jin D, Wang R, Marshall D, Gossage D, Smith V. Selective Inhibition of MMP9 Using a Monoclonal Antibody As a Therapeutic Strategy for Rheumatoid Arthritis. Arthritis Rheumatol 2016;68 (suppl 10)."},{"key":"10.1016\/j.bcp.2023.115622_b0545","article-title":"Targeting matrix metalloproteases: a promising strategy for herbal medicines to treat rheumatoid arthritis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:43:58Z","timestamp":1757771038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223002137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":109,"alternative-id":["S0006295223002137"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115622","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential therapeutic targets beyond cytokines and Janus kinases for autoimmune arthritis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115622"}}